CTNM Contineum Therapeutics, Inc. Class A Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Contineum Therapeutics (CTNM) Stock: Buy, Sell, or Hold?

$10.30
+0.78 (+8.19%) ▲
5d: +7.74% 30d: -23.02% 90d: -30.5%
Open in Live Scanner Earnings: Nov 05, 2026 0d Updated Nov 9, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (58%)
Quality Score
44/100
Position
FAIR
30-Day Fair Range
$7.79 – $11.58
Position: FAIR
Forward P/E & Valuation
-5.2x
Next 12M consensus est.
Wall Street Target
$22.14
+115.0% upside
Options IV & Volume
32th pct IV
HIGH volume confirmation
Support / Resistance
$8.02 / $10.50
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: CTNM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When CTNM Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CTNM is currently trading at $10.30, which is considered fair relative to its 30-day fair value range of $7.79 to $11.58.

Technical Outlook: Technically, CTNM is in a strong uptrend. The price is approaching resistance at $10.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 8.2% recently.

Market Sentiment: CTNM scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.14 (+115.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $7.79 - $11.58
Company Quality Score 44/100 (HOLD)
Options IV Signal 32th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 58.3%

Trading Range & Key Levels

30-Day Trading Range $7.79 - $11.58
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$1.76 (17.1%)
Support Level $8.02
Resistance Level $10.50
Current Trend Strong Uptrend
Technical data as of Nov 9, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Options fairly priced (IV 32th percentile)
  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+8.2%)
  • BULLISH: Trading 115.0% below Wall St target ($22.14)
  • WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -5.19
Wall Street Target $22.14 (+115.0%)
Share CTNM Analysis

Share this live CTNM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CTNM)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits shows a bullish sentiment towards $CTNM with one message expressing optimism about its price movement.
Key Retail Themes: Price movement
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 5:26 AM ET
Data refreshes hourly during market hours. Next update: 6:26 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CTNM.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 41 HOLD
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 29 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 68 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 45 HOLD
SYRE
Spyre Therapeutics Inc.
STRONG BUY
18 analysts
$122 40 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CTNM Research Pages
CTNM Technical Chart CTNM Price Prediction CTNM Intrinsic Value DCF CTNM Earnings Date Why is CTNM Moving Today? CTNM Investment Advisor CTNM Fair Price Analyzer CTNM Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals